COSCIENS Biopharma Inc. (TSX:CSCI)

COSCIENS Biopharma Statistics

Total Valuation

TSX:CSCI has a market cap or net worth of CAD 9.36 million. The enterprise value is 509,960.

Market Cap	9.36M
Enterprise Value	509,960

Important Dates

The next estimated earnings date is Wednesday, March 25, 2026.

Earnings Date	Mar 25, 2026
Ex-Dividend Date	n/a

Share Statistics

TSX:CSCI has 3.18 million shares outstanding. The number of shares has increased by 30.54% in one year.

Current Share Class	3.18M
Shares Outstanding	3.18M
Shares Change (YoY)	+30.54%
Shares Change (QoQ)	+0.07%
Owned by Insiders (%)	0.55%
Owned by Institutions (%)	0.12%
Float	2.92M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.74
PB Ratio	1.32
P/TBV Ratio	1.32
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-0.02
EV / Sales	0.04
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-0.03

Financial Position

The company has a current ratio of 3.47, with a Debt / Equity ratio of 0.43.

Current Ratio	3.47
Quick Ratio	2.54
Debt / Equity	0.43
Debt / EBITDA	n/a
Debt / FCF	-0.20
Interest Coverage	-47.69

Financial Efficiency

Return on equity (ROE) is -118.80% and return on invested capital (ROIC) is -131.40%.

Return on Equity (ROE)	-118.80%
Return on Assets (ROA)	-14.01%
Return on Invested Capital (ROIC)	-131.40%
Return on Capital Employed (ROCE)	-38.15%
Revenue Per Employee	315,281
Profits Per Employee	-519,060
Employee Count	40
Asset Turnover	0.27
Inventory Turnover	1.99

Taxes

In the past 12 months, TSX:CSCI has paid 1.51 million in taxes.

Income Tax	1.51M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -30.37% in the last 52 weeks. The beta is 1.45, so TSX:CSCI's price volatility has been higher than the market average.

Beta (5Y)	1.45
52-Week Price Change	-30.37%
50-Day Moving Average	3.01
200-Day Moving Average	4.03
Relative Strength Index (RSI)	48.88
Average Volume (20 Days)	3,199

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TSX:CSCI had revenue of CAD 12.61 million and -20.76 million in losses. Loss per share was -6.58.

Revenue	12.61M
Gross Profit	5.59M
Operating Income	-10.56M
Pretax Income	-19.26M
Net Income	-20.76M
EBITDA	-9.24M
EBIT	-10.56M
Loss Per Share	-6.58

Balance Sheet

The company has 11.87 million in cash and 3.02 million in debt, with a net cash position of 8.85 million or 2.78 per share.

Cash & Cash Equivalents	11.87M
Total Debt	3.02M
Net Cash	8.85M
Net Cash Per Share	2.78
Equity (Book Value)	7.08M
Book Value Per Share	2.22
Working Capital	13.72M

Cash Flow

In the last 12 months, operating cash flow was -13.93 million and capital expenditures -1.35 million, giving a free cash flow of -15.28 million.

Operating Cash Flow	-13.93M
Capital Expenditures	-1.35M
Free Cash Flow	-15.28M
FCF Per Share	-4.80

Margins

Gross margin is 44.30%, with operating and profit margins of -83.74% and -164.63%.

Gross Margin	44.30%
Operating Margin	-83.74%
Pretax Margin	-152.68%
Profit Margin	-164.63%
EBITDA Margin	-73.27%
EBIT Margin	-83.74%
FCF Margin	n/a

Dividends & Yields

TSX:CSCI does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-30.54%
Shareholder Yield	-30.54%
Earnings Yield	-221.84%
FCF Yield	-163.28%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on May 3, 2024. It was a reverse split with a ratio of 0.25.

Last Split Date	May 3, 2024
Split Type	Reverse
Split Ratio	0.25

Scores

TSX:CSCI has an Altman Z-Score of -1 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1
Piotroski F-Score	4